跳至主要内容
临床试验/NCT01391312
NCT01391312已完成4 期

A Pilot Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Glabellar Lines - Establishing Patient Satisfaction

Allergan0 个研究点目标入组 40 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
40
主要终点
Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30

研究概览

简要总结

This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Moderate to severe glabellar wrinkles (frown lines)

排除标准

  • Previous treatment with botulinum toxin therapy of any serotype
  • Facial non-ablative resurfacing laser or light treatment, microdermabrasion, or superficial peels within 3 months
  • Any facial cosmetic procedure with medium depth to deep facial chemical peels (e.g., trichloroacetic acid and phenol), mid-facial or periorbital laser skin resurfacing or permanent make-up within 6 months
  • Mid-facial or periorbital treatment with non-permanent soft tissue fillers
  • Subjects planning a facial cosmetic procedure or visible scars
  • Previous cosmetic surgery to the upper face(e.g., prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery)
  • Diagnoses of Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis
  • History of facial nerve palsy
  • A planned extended absence during the study

研究组 & 干预措施

botulinum toxin Type A

Active Comparator

Botulinum toxin Type A 20U (total dose) injected into the glabellar region on Day 0.

干预措施: botulinum toxin Type A (Biological)

placebo (Normal Saline)

Placebo Comparator

Normal Saline (placebo) injected into the glabellar region on Day 0.

干预措施: normal saline (placebo) (Drug)

结局指标

主要结局

Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30

时间窗: Day 30

Subjects assessed the improvement of their glabellar lines (area between the eyebrows) by answering the question: Compared to before receiving the study treatment, How do you currently feel about the appearance of your glabellar lines? on a 7-point scale where 0=Very much improved, 1=Much improved, 2=Minimally improved, 3=No change, 4=Minimally worse, 5=Much worse, 6=Very much worse. Improvement was defined as responses: 0=Very much improved, 1=Much improved and 2=Minimally improved.

次要结局

  • Percentage of Facial Wrinkle Scale Responders at Maximum Attempted Muscle Contraction at Day 30(Day 30)
  • Percentage of Facial Wrinkle Scale Responders at Maximum Attempted Muscle Contraction at Day 60(Day 60)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验